M&t bank acquires Inspire medical systems
M&T Bank Corp acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with…
Company lists
Cardiac devices, research tools, neurology, oncology, startups and more: the companies building life sciences in Minnesota, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 469 life sciences companies in Minnesota, last 24 months: 27 M&A deals · 25 funding rounds · 6 Contracts · 2 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Apr 2026.
M&T Bank Corp acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with…
France-based consulting and engineering expert APL, which specialises in the design and construction of data centres, announced that private investment platform Capza and investment fund…
Sivik Global Healthcare LLC bought a new stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) during the 4th quarter, Holdings Channel reports.
Minnesota Medical Technologies Corporation, a leading innovator in continence care solutions, today announced it has raised $20.6 million of new capital through a Series A preferred…
Monteris Medical, a private company leading the field in minimally invasive neurosurgery with its NeuroBlate® System for magnetic resonance-guided laser interstitial thermal therapy…
Minnesota Medical Technologies – $20.6M
Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) has secured a USD 90 million strategic investment from Medtronic plc (NASDAQ: MDT).
CivicPlus has acquired Streamline
private equity firm GTCR BC Holdings LLC’s acquisition of Surmodics Inc.
Anteris Technologies Global Corp has announced a binding agreement for a private placement valued at approximately AUD 38.5 million (USD 25.2 million).
IDRX, an Indonesia-based crypto startup, has raised USD 300,000 in a pre‑seed round, according to Kontan. The round was led by eMerge by MDI Ventures, with participation from Indodax,…
FOXO announces the closing of the acquisition of Vector Biosource Inc.
Surmodics struck a deal to sell to private equity, although that move remains under government scrutiny.
On July 30, 2025, Celcuity Inc. entered into an underwriting agreement with several underwriters to issue and sell $175 million in Convertible Senior Notes, with an additional option…
On July 30, 2025, Celcuity Inc. entered into an underwriting agreement to issue and sell shares of common stock and pre-funded warrants, completing the offering on July 31, 2025, with…
ABM Respiratory Care (ABMRC), a medical technology company focused on developing and globally commercializing novel airway clearance and ventilation solutions, today announced the…
Alpheus Medical, Inc., a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers, today announced the closing of an…
Catheter Precision, Inc. (VTAK:NYSE-American) today announced that it has signed a definitive agreement to acquire, through its newly formed, 82% owned subsidiary, Cardionomix, Inc.…
Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update…
Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced that it has received the first tranche of financing from Renovaro Biosciences, Inc.…
DGIMED Ortho (Minnetonka, Minnesota) reported completing a $3.4 million Series A round of financing to support the further development of a new system to assist orthopedic surgeons in…
BridgePoint Medical (Minneapolis), a private company developing technology in the field of interventional cardiology for crossing coronary and peripheral chronic total occlusions (CTO),…
Celleration (Eden Prairie, Minnesota), developer of the patented MIST therapy system, an ultrasound device that promotes wound healing through cellular stimulation while removing…
Biovest International Inc. (Tampa, Fla.) Loan N/A $1.5 Biovest received a loan from the state of Minnesota, the city of Coon Rapids and real estate developer JMS Holdings LLC (2/25)
Apnex Medical (Minneapolis) said it has completed a $16.1 million private equity financing to complete development and initiate clinical studies of its active implantable technology…
ProUroCare Medical (Golden Valley, Minnesota) reported the closing of its public offering of 3.050 million units at $1 a unit, before the underwriting discount.
Altheus secured $3.6M in a round led by Prolog Ventures, with participation from the Oklahoma Seed Capital Fund and Oklahoma Equity Partners
Lutonix (Minneapolis) reported the close of a $20 million Series B financing.
Anulex Technologies (Minneapolis) closed its fourth round of private equity financing, totaling roughly $10.2 million.
Few life sciences companies in Minnesota publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 306 active companies.

Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
NeurologyUS$530.00m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of implantable technology for hypertension and heart failure
Cardiac and vascular disordersUS$368.50m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable baroreflex activation devices and minimally invasive electrode delivery systems
CPC A61N1/36114, A61N1/05, A61N1/36117Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical devices for the treatment of mitral regurgitation
Cardiac and vascular disordersUS$254.65m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61F2/2418, A61B18/1402, A61B18/042Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a catheter-based system for patients suffering from COPD
PulmonologyUS$226.91m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Minimally invasive therapeutic devices for respiratory, esophageal and catheter-based interventions
CPC A61B18/1492, A61B18/1477, A61B18/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Minimally invasive robotic laser thermotherapy
NeurologyUS$199.38m across 14 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical devices for the treatment of Type 2 diabetes
DiabetesUS$190.43m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Pulsed electric field tissue ablation devices for medical/clinical applications
CPC A61B18/1492, A61B18/00, A61N1/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
Genitourinary disordersUS$157.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Cloud based data research platform
Enterprise information managementUS$153.62m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of neurostimulation device to treat sleep apnea
Sleep medicineUS$109.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neurostimulation systems for diagnosing and treating sleep‑disordered breathing
CPC A61N1/3611, A61N1/3601, A61B5/4818Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of minimally -invasive devise for valve repair
Cardiac and vascular disordersUS$108.67m across 14 disclosed equity rounds
Darker bars = larger roundsFocus: Minimally invasive cardiac valve repair devices and suture anchoring technologies.
CPC A61F2/2457, A61B17/0469, A61F2/2466Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a neuromodulating device for treating migraine
NeurologyUS$107.69m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neurostimulation devices for headache relief with wireless charging and communication
CPC A61N1/0526, A61N1/3787, A61N1/37235Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of oncolytic-virus-based immunotherapies for cancer treatment
ImmunotherapyUS$87.88m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered rhabdoviral vectors for oncolytic cancer therapy and viral antibody diagnostics
CPC C07K14/005, G01N33/5017, G01N33/56983Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of Sonodynamic therapy device for brain cancer
NeurologyUS$68.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene repair and gene-editing technology to create animal models
Life sciences platforms and toolsUS$65.54m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Livestock genome editing and non‑meiotic allele introgression using pluripotent stem cells
CPC A01K67/0275, A01K67/0276, C12N15/8509Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of catheters for acute ischemic stroke therapy
NeurologyUS$66.48m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Neurovascular catheter systems for aspiration, thrombectomy, and embolic protection in cerebral vessels
CPC A61B17/22, A61B17/221, A61M25/09Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer offering electrotherapy for treating diabetes
DiabetesFocus: Bioelectronic neuromodulation devices for metabolic disease, targeting liver and gastrointestinal nerves
CPC A61B18/02, A61B18/06, A61B18/1492Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Satiety induction through vagal nerve block
ObesityUS$62.10m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neuromodulation systems for metabolic and cardiovascular regulation
CPC A61N1/36007, A61N1/3787, A61N1/05Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of human hepatocytes for research and clinical applications
Life sciences platforms and toolsFocus: Engineered human hepatocyte production, genetic modification, and biliary delivery platforms
CPC C12N5/067, A61K35/407, A61K48/0041Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Radiofrequency ablation device for overactive bladder treatment
Genitourinary disordersUS$48.28m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Device for pulmonary hypertension
Cardiac and vascular disordersUS$44.98m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable cardiovascular devices that modulate pulsatile pressure to treat pulmonary hypertension
CPC A61B17/12036, A61M25/104, A61M60/497Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a therapeutic medical device for treating sleep disorders
Sleep medicineUS$44.75m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Cryogenic adipose tissue ablation devices for obstructive sleep apnea treatment
CPC A61F7/12, A61B18/0218, A61B18/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Innovating ultrasound-guided solutions to transform patient experience, improve safety, lower costs
OrthopedicsUS$40.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of wearable prosthesis for people with sensory peripheral neuropathy
NeurologyUS$39.95m across 10 disclosed equity rounds
Darker bars = larger roundsFocus: Sensory nerve stimulation and feedback systems for gait and balance improvement
CPC A61B5/4023, A61F2/30721, A61N1/3606Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of medical technology services for people suffering from incontinence
Genitourinary disordersUS$31.95m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of surgical mesh for wound management
Wound careUS$29.42m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of neuromodulation technology intended to treat patients suffering from chronic diseases
NeurologyFocus: Personalized vagus nerve stimulation and AI-driven seizure/depression monitoring
CPC A61N1/36053, A61B5/4094, G16H40/63Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of invisible and removable braces
Dental disordersEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of platform to manage sample preparation and diagnostic solutions
NeurologyUS$24.95m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Multiplex biosensor platforms for detecting and enriching disease biomarkers
CPC G01N33/54326, G01N33/54313, B01D15/3804Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of devices for ventilation and airway clearance
PulmonologyUS$24.80m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of lymphedema and venous ulcer treatment therapy and pumps
Cardiac and vascular disordersUS$23.20m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical technology intended to revolutionize gastric bypass
Metabolic diseasesFocus: Magnetic compression devices for gastrointestinal anastomosis and organ sealing
CPC A61B17/1114, A61K31/19, A23L33/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Surgical tool for ear tube procedures
Ent disordersUS$21.81m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a medical device to treat tricuspid regurgitation
Cardiac and vascular disordersFocus: Transcatheter heart valve delivery systems with side‑entry and cinching mechanisms
CPC A61F2/2418, A61F2/2427, A61F2/24Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of implanted hearing devices
Ent disordersUS$19.38m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of electromagnetic feeding tube placement devices
GastroenterologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a microarray platform and gene expression profiling system for post-genomic applications
Life sciences platforms and toolsUS$17.89m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of regenerative biomaterials for tissue repair and replacement
Regenerative medicineFocus: Engineered tissue implants for cardiovascular valves, grafts, and nerve repair
CPC A61B17/1128, A61L27/3641, A61L27/3633Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for rare and orphan disease conditions
Cardiac and vascular disordersEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of orbital atherectomy platform for treating calcified and fibrotic plaque
Cardiac and vascular disordersUS$15.67m across 11 disclosed equity rounds
Darker bars = larger roundsFocus: Coronary rotational atherectomy and intravascular lithotripsy devices for plaque removal
CPC A61B17/320758, A61B17/320725, A61B17/3207Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of targeted therapies for cancer patients
OncologyUS$15.43m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive biomarker assays and companion diagnostics for PI3K/mTOR cancer therapies
CPC G01N33/5011, A61K31/5377, C12N5/0693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of cell therapies for treating cancer
ImmunotherapyUS$15.17m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61N5/0624, A61M25/02, A61L2/24Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical diagnostic technology designed for rapid, accurate pathogen detection
Clinical genomicsUS$14.70m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Hand tools for fastener removal, grip enhancement, and socket adapter technologies.
CPC B25B15/008, B25B15/005, B25B13/065Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of medical devices for ENT surgeons to perform ear tube procedures in child
Ent disordersUS$14.38m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A45D29/007, B60L3/0069, G06V30/416Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of multi-phase prolonged release drug delivery platform for localized treatments
Pain managementUS$13.92m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/445, A61K9/0024, A61K38/1866Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of precision imaging and radiation therapy for the treatment of cancer patients
OncologyUS$12.23m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Respiratory gating and breath‑hold monitoring for medical imaging using fiber‑optic sensors
CPC G01D5/35316, A61B5/02055, A61B5/0816Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovating with silk-derived proteins for healthier, sustainable product development
OphthalmologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing therapies targeting cancer drug resistance and tumor evolution
OncologyUS$11.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of minimally invasive products for uterine bleeding
Women healthUS$10.91m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provides smart devices and app-based solution for managing diabetes
Disease self managementUS$9.73m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Remote glucose monitoring and telehealth analytics for diabetes management
CPC A61B5/157, A61B5/150572, G16H40/67Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Improving CPR outcomes through innovative patient positioning solutions and training
Cardiac and vascular disordersEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Minnesota on RadarDiscover top life sciences companies in Minnesota across medical devices, research tools, and therapeutics. Browse life sciences startups in Minnesota and companies hiring in life sciences.
Companies developing treatments and devices for cardiac and vascular conditions.

Developer of implantable technology for hypertension and heart failure
Cardiac and vascular disorders
Developer of medical devices for the treatment of mitral regurgitation
Cardiac and vascular disorders
Provider of minimally -invasive devise for valve repair
Cardiac and vascular disorders
Device for pulmonary hypertension
Cardiac and vascular disorders
Provider of lymphedema and venous ulcer treatment therapy and pumps
Cardiac and vascular disordersCompanies providing life sciences research platforms, instruments, and tools.

Developer of gene repair and gene-editing technology to create animal models
Life sciences platforms and tools
Developer of human hepatocytes for research and clinical applications
Life sciences platforms and tools
Developer of nanocapsules for cancer treatment
Life sciences platforms and tools
Biomimetic tools for 3D cell culture
Life sciences platforms and tools
Biotech company advancing regenerative medicine through autologous cellular therapy solutions
Life sciences platforms and toolsCompanies developing diagnostics and therapies for neurological conditions.

Developing non-invasive therapy for concussion
Neurology
Developer of implantable neuromodulation technologies designed for treatment of chronic conditions
Neurology
Developer of a neurostimulation platform for spinal cord injury
Neurology
A device for the treatment of neurological disorders
Neurology
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
NeurologyLife sciences companies focused on cancer therapies and care.

Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
Genitourinary disorders
Developer of oncolytic-virus-based immunotherapies for cancer treatment
Immunotherapy
Developer of Sonodynamic therapy device for brain cancer
Neurology
Developer of targeted therapies for cancer patients
Oncology
Developer of cell therapies for treating cancer
ImmunotherapyRecently founded life sciences companies in Minnesota.

Developer of neuromodulation technology intended to treat patients suffering from chronic diseases
Neurology
Developer of solutions for stroke thrombectomy procedures
Cardiac and vascular disordersDeveloper of an implantable neurostimulation device for moderate-to-severe sleep apnea
Sleep medicine
Developer of protein-based eye drops
Ophthalmology
Developer of sensor-based breath diagnostic platforms
PulmonologyLife sciences companies in Minnesota with hiring activity.

Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
Neurology
Developer of implantable technology for hypertension and heart failure
Cardiac and vascular disorders
Provider of a catheter-based system for patients suffering from COPD
Pulmonology
Developer of medical devices for the treatment of Type 2 diabetes
Diabetes
Developer of oncolytic-virus-based immunotherapies for cancer treatment
ImmunotherapyPublicly listed life sciences companies in Minnesota.

Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
Neurology
Developer of implantable technology for hypertension and heart failure
Cardiac and vascular disorders
Developer of neurostimulation device to treat sleep apnea
Sleep medicine
Satiety induction through vagal nerve block
Obesity
Provider of lymphedema and venous ulcer treatment therapy and pumps
Cardiac and vascular disordersThe most-installed Android apps published by life sciences companies headquartered in Minnesota — 895K installs between them. 10 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
CIN U73200DL2007FTC227985The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Minnesota compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 469 life sciences companies in Minnesota among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of Minnesota maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
109 life sciences companies in Minnesota have recorded equity funding, US$3.74bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
NeurologyDeveloper of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
Cardiac and vascular disordersDeveloper of implantable technology for hypertension and heart failure
Cardiac and vascular disordersDeveloper of medical devices for the treatment of mitral regurgitation
PulmonologyProvider of a catheter-based system for patients suffering from COPD
NeurologyMinimally invasive robotic laser thermotherapy
DiabetesDeveloper of medical devices for the treatment of Type 2 diabetes
Genitourinary disordersDeveloper of a therapeutic solution to treat prostate, kidney, and bladder cancer
Enterprise information managementCloud based data research platform
Sleep medicineDeveloper of neurostimulation device to treat sleep apnea
Cardiac and vascular disordersProvider of minimally -invasive devise for valve repair
NeurologyDeveloper of a neuromodulating device for treating migraine
ImmunotherapyDeveloper of oncolytic-virus-based immunotherapies for cancer treatment
NeurologyDeveloper of Sonodynamic therapy device for brain cancer
Life sciences platforms and toolsDeveloper of gene repair and gene-editing technology to create animal models
NeurologyDeveloper of catheters for acute ischemic stroke therapy
Founders
Details not available
DiabetesDeveloper offering electrotherapy for treating diabetes
US$530.00m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$368.50m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable baroreflex activation devices and minimally invasive electrode delivery systems
CPC A61N1/36114, A61N1/05, A61N1/36117Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$254.65m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61F2/2418, A61B18/1402, A61B18/042Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$226.91m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Minimally invasive therapeutic devices for respiratory, esophageal and catheter-based interventions
CPC A61B18/1492, A61B18/1477, A61B18/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$199.38m across 14 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$190.43m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Pulsed electric field tissue ablation devices for medical/clinical applications
CPC A61B18/1492, A61B18/00, A61N1/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$157.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$153.62m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$109.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neurostimulation systems for diagnosing and treating sleep‑disordered breathing
CPC A61N1/3611, A61N1/3601, A61B5/4818Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$108.67m across 14 disclosed equity rounds
Darker bars = larger roundsFocus: Minimally invasive cardiac valve repair devices and suture anchoring technologies.
CPC A61F2/2457, A61B17/0469, A61F2/2466Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$107.69m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neurostimulation devices for headache relief with wireless charging and communication
CPC A61N1/0526, A61N1/3787, A61N1/37235Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$87.88m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered rhabdoviral vectors for oncolytic cancer therapy and viral antibody diagnostics
CPC C07K14/005, G01N33/5017, G01N33/56983Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$68.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$65.54m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Livestock genome editing and non‑meiotic allele introgression using pluripotent stem cells
CPC A01K67/0275, A01K67/0276, C12N15/8509Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$66.48m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Neurovascular catheter systems for aspiration, thrombectomy, and embolic protection in cerebral vessels
CPC A61B17/22, A61B17/221, A61M25/09Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Bioelectronic neuromodulation devices for metabolic disease, targeting liver and gastrointestinal nerves
CPC A61B18/02, A61B18/06, A61B18/1492Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in Minnesota. 216 of 306 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Surgical instrumentsManufacturer of a wide range of surgical wound closure devices
OphthalmologyInnovating with silk-derived proteins for healthier, sustainable product development
Surgical instrumentsDeveloper of medical endoscopes for surgical applications
Founders
Details not available
Life sciences platforms and toolsProvider of cryopreservation technology for the cell therapy supply chain
Life sciences platforms and toolsPioneering precision in early-phase drug discovery with advanced biosensor technology
Enterprise information managementCloud based data research platform
Life sciences platforms and toolsDeveloper of human hepatocytes for research and clinical applications
Founders
Details not available
OncologyDeveloper of targeted therapies for cancer patients
NeurologyProvider of wearable prosthesis for people with sensory peripheral neuropathy
Audio techDeveloper of AI-based hearing aids
Ent disordersPortfolio of audiometric assessment instrumentation
OncologyProvider of cell therapy research, patient support, and donor registry
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$153.62m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered human hepatocyte production, genetic modification, and biliary delivery platforms
CPC C12N5/067, A61K35/407, A61K48/0041Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.43m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive biomarker assays and companion diagnostics for PI3K/mTOR cancer therapies
CPC G01N33/5011, A61K31/5377, C12N5/0693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$39.95m across 10 disclosed equity rounds
Darker bars = larger roundsFocus: Sensory nerve stimulation and feedback systems for gait and balance improvement
CPC A61B5/4023, A61F2/30721, A61N1/3606Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: AI-driven social networking recommendation and remote conversation facilitation platforms
CPC H04W64/00, G06F16/9535, G06F16/437Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Minnesota with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Genitourinary disordersProvider of medical technology services for people suffering from incontinence
Life sciences platforms and toolsAccelerating cell-based therapies with innovative human platelet lysate solutions
PulmonologyDeveloper of therapeutic device for pneumothorax decompression
Hospital equipmentProvider of active temperature-controlled containers for pharmaceutical supply chain management
Imaging diagnosticsDeveloper of treatment for hypoxemic respiratory failure
Pain managementDeveloper of automated lymphatic drainage therapy for pain relief and lymphatic health
ImmunotherapyCell culture solutions and manufacturing services for biotech, pharma, and research
Life sciences platforms and toolsPioneering precision in early-phase drug discovery with advanced biosensor technology
Life sciences platforms and toolsProvider of cryopreservation technology for the cell therapy supply chain
Life sciences techProvides ECG data analysis solutions for preclinical studies
Cardiac and vascular disordersDeveloper of percutaneous ventricular assist devices for high-risk patients
Cardiac and vascular disordersDeveloper of a device intended to improve aortic arch surgical outcomes
US$31.95m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Emergency medical chest sealing devices for trauma care
CPC A61F13/0233Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.26m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Microbubble contrast agents and ultrasound‑guided imaging/therapy devices for cardiac and musculoskeletal diagnostics.
CPC A61M5/00, A61M5/007, A61B8/0883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$852k across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Wearable physiological monitoring devices and signal‑processing algorithms for ECG and respiration
CPC A61B5/7203, A61B5/7253, A61B5/0468Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Minnesota founded in the last four years, newest first.
Developer of implantable bionic pump technology for lymphedema treatment
Founders
Details not available
NeurologyDeveloper of implantable neuromodulation technologies designed for treatment of chronic conditions
Developer of hemodynamic monitor providing continuous cardiac output for pediatric patients
Cardiac and vascular disordersDeveloper of a device intended to improve aortic arch surgical outcomes
NeurologyDeveloper of neuromodulation technology intended to treat patients suffering from chronic diseases
Developer of an implantable neurostimulation device for moderate-to-severe sleep apnea
Founders
Details not available
NeurologyDeveloper of minimally invasive thin film electrodes for the diagnosis of neurological conditions
Life sciences techProvider of automation software for clinical researchers
PulmonologyDeveloper of sensor-based breath diagnostic platforms
OphthalmologyDeveloper of protein-based eye drops
Infectious diseasesProvider of a medical device that collects nasal specimens to test for pathogens
GastroenterologyDeveloper of medical device to control chronic symptoms of gastroparesis
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Personalized vagus nerve stimulation and AI-driven seizure/depression monitoring
CPC A61N1/36053, A61B5/4094, G16H40/63Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.40m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Silk protein-based ophthalmic drugs and oxidation-enabled silk fibroin surface coating technologies.
CPC C09D189/00, A61K38/1767Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Sleep medicineDeveloper of neurostimulation device to treat sleep apnea
Cardiac and vascular disordersProvider of technologies for developing heart valve
Life sciences platforms and toolsDeveloper of biotech reagents, instruments and clinical diagnostic products
Cardiac and vascular disordersDeveloper of implantable technology for hypertension and heart failure
OncologyDeveloper of targeted therapies for cancer patients
GenomicsProvider of epigenetic biomarkers discovery and development platform
Founders
Details not available
OncologyDeveloper of therapeutic solutions for the treatment of cancer
Founders
Details not available
NeurologyDeveloper of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
DiabetesDeveloper of medical devices for the treatment of Type 2 diabetes
Genitourinary disordersImaging system for diagnosis of prostate diseases
Cardiac and vascular disordersDeveloper of magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias
DermatologyDeveloper of platelet-derived exosomes for skincare and restorative clinical applications
US$109.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neurostimulation systems for diagnosing and treating sleep‑disordered breathing
CPC A61N1/3611, A61N1/3601, A61B5/4818Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$368.50m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable baroreflex activation devices and minimally invasive electrode delivery systems
CPC A61N1/36114, A61N1/05, A61N1/36117Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.43m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive biomarker assays and companion diagnostics for PI3K/mTOR cancer therapies
CPC G01N33/5011, A61K31/5377, C12N5/0693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Machine‑learning analysis and quality control of epigenetic DNA data for health diagnostics
CPC C12Q1/6825, G16H50/20, G16H10/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$530.00m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$190.43m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Pulsed electric field tissue ablation devices for medical/clinical applications
CPC A61B18/1492, A61B18/00, A61N1/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.10m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in Minnesota. Open a company to see what it sells, who runs it and how far it has come.
45 life sciences companies in Minnesota work in cardiac and vascular disorders. Shown: the best-documented.
Cardiac and vascular disordersProvider of lymphedema and venous ulcer treatment therapy and pumps
Cardiac and vascular disordersDeveloper of implantable technology for hypertension and heart failure
Cardiac and vascular disordersDeveloper of magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias
Cardiac and vascular disordersDeveloper of medical devices for the treatment of mitral regurgitation
Cardiac and vascular disordersDevice for pulmonary hypertension
Founders
Details not available
Cardiac and vascular disordersDeveloper of drugs for rare and orphan disease conditions
Cardiac and vascular disordersImproving CPR outcomes through innovative patient positioning solutions and training
Cardiac and vascular disordersDeveloper of medical devices for chronic venous insufficiency
GenomicsPersonalized hypertension treatment through DNA analysis for better medication selection
Cardiac and vascular disordersProvider of minimally -invasive devise for valve repair
Regenerative medicineDeveloper of regenerative biomaterials for tissue repair and replacement
Cardiac and vascular disordersInnovative cardiopulmonary exercise testing solutions for streamlined diagnosis and therapy optimization
US$23.20m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$368.50m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable baroreflex activation devices and minimally invasive electrode delivery systems
CPC A61N1/36114, A61N1/05, A61N1/36117Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.10m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$254.65m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61F2/2418, A61B18/1402, A61B18/042Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$44.98m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable cardiovascular devices that modulate pulsatile pressure to treat pulmonary hypertension
CPC A61B17/12036, A61M25/104, A61M60/497Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.11m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Genetic diagnostics and therapeutics for hypertension and coronavirus infections
CPC C12Q1/6883, C12Q1/701Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$108.67m across 14 disclosed equity rounds
Darker bars = larger roundsFocus: Minimally invasive cardiac valve repair devices and suture anchoring technologies.
CPC A61F2/2457, A61B17/0469, A61F2/2466Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered tissue implants for cardiovascular valves, grafts, and nerve repair
CPC A61B17/1128, A61L27/3641, A61L27/3633Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
37 life sciences companies in Minnesota work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsProvider of a microarray platform and gene expression profiling system for post-genomic applications
Life sciences platforms and toolsDeveloper of gene repair and gene-editing technology to create animal models
Life sciences platforms and toolsBiomimetic tools for 3D cell culture
Founders
Details not available
Life sciences platforms and toolsDeveloper of human hepatocytes for research and clinical applications
Founders
Details not available
GenomicsPersonalized hypertension treatment through DNA analysis for better medication selection
Life sciences platforms and toolsAccelerating cell-based therapies with innovative human platelet lysate solutions
Life sciences platforms and toolsManufacturer of recombinant proteins using plant-based molecular farming for research
Life sciences platforms and toolsDeveloper of nanocapsules for cancer treatment
Life sciences platforms and toolsBiotech company advancing regenerative medicine through autologous cellular therapy solutions
Founders
Details not available
Life sciences platforms and toolsDeveloper of biotech reagents, instruments and clinical diagnostic products
Life sciences platforms and toolsDeveloper of reagents and kits for biotech research and development
Founders
Details not available
Life sciences platforms and toolsSupplier of Control Microorganisms
US$17.89m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$65.54m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Livestock genome editing and non‑meiotic allele introgression using pluripotent stem cells
CPC A01K67/0275, A01K67/0276, C12N15/8509Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered human hepatocyte production, genetic modification, and biliary delivery platforms
CPC C12N5/067, A61K35/407, A61K48/0041Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.11m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Genetic diagnostics and therapeutics for hypertension and coronavirus infections
CPC C12Q1/6883, C12Q1/701Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.20m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$717k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: High-resolution hydrogel inks and multi-plane stereolithography for advanced 3D printing
CPC B29C64/393, B29C64/40, B29C64/124Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
25 life sciences companies in Minnesota work in neurology. Shown: the best-documented.
NeurologyDeveloper of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
NeurologyMinimally invasive robotic laser thermotherapy
NeurologyDeveloper of catheters for acute ischemic stroke therapy
Founders
Details not available
NeurologyProvider of wearable prosthesis for people with sensory peripheral neuropathy
NeurologyDeveloper of a neuromodulating device for treating migraine
Cardiac and vascular disordersDeveloper of drugs for rare and orphan disease conditions
NeurologyDeveloper of Sonodynamic therapy device for brain cancer
NeurologyProvider of platform to manage sample preparation and diagnostic solutions
Developer of brain mapping software utilizing resting state functional MRI
Founders
Details not available
Healthcare itAI and cloud-based platform for visualizing brain MRI images
Healthcare itDeveloper of screening tools for Alzheimer's disease
NeurologyDeveloper of medical devices for the treatment of neurodegenerative diseases
US$530.00m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$199.38m across 14 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$66.48m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Neurovascular catheter systems for aspiration, thrombectomy, and embolic protection in cerebral vessels
CPC A61B17/22, A61B17/221, A61M25/09Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$39.95m across 10 disclosed equity rounds
Darker bars = larger roundsFocus: Sensory nerve stimulation and feedback systems for gait and balance improvement
CPC A61B5/4023, A61F2/30721, A61N1/3606Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$107.69m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable neurostimulation devices for headache relief with wireless charging and communication
CPC A61N1/0526, A61N1/3787, A61N1/37235Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$68.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$24.95m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Multiplex biosensor platforms for detecting and enriching disease biomarkers
CPC G01N33/54326, G01N33/54313, B01D15/3804Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.74m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
22 life sciences companies in Minnesota work in oncology. Shown: the best-documented.
OncologyDeveloper of targeted therapies for cancer patients
ImmunotherapyDeveloper of oncolytic-virus-based immunotherapies for cancer treatment
Genitourinary disordersDeveloper of a therapeutic solution to treat prostate, kidney, and bladder cancer
ImmunotherapyDeveloper of cell therapies for treating cancer
Founders
Details not available
NeurologyDeveloper of Sonodynamic therapy device for brain cancer
Pain managementDeveloper of multi-phase prolonged release drug delivery platform for localized treatments
OncologyDeveloping therapies targeting cancer drug resistance and tumor evolution
OncologyDiagnostic company, now in Chapter 7 bankruptcy proceedings
Life sciences platforms and toolsDeveloper of nanocapsules for cancer treatment
ImmunotherapyNovel oncolytic immunotherapy transforming immune cells to fight cancer
OncologyDeveloper of precision imaging and radiation therapy for the treatment of cancer patients
Developer of implantable bionic pump technology for lymphedema treatment
Founders
Details not available
US$15.43m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive biomarker assays and companion diagnostics for PI3K/mTOR cancer therapies
CPC G01N33/5011, A61K31/5377, C12N5/0693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$87.88m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered rhabdoviral vectors for oncolytic cancer therapy and viral antibody diagnostics
CPC C07K14/005, G01N33/5017, G01N33/56983Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$157.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.17m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61N5/0624, A61M25/02, A61L2/24Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$68.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$13.92m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/445, A61K9/0024, A61K38/1866Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.20m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$671k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.23m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Respiratory gating and breath‑hold monitoring for medical imaging using fiber‑optic sensors
CPC G01D5/35316, A61B5/02055, A61B5/0816Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
119 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.